Douglas S. Berkman

NYU Langone Health

Papers

1

Total Citations

155

H-Index

1

About

Douglas S. Berkman is a leading urologic oncologist and researcher whose work has significantly advanced the field of minimally invasive kidney cancer surgery. His primary research focuses on robotic partial nephrectomy, particularly for complex and challenging tumors. In his landmark multi-institutional study of 446 consecutive cases, Berkman demonstrated that robotic partial nephrectomy for hilar tumors—those located near the kidney’s critical blood vessels—is both safe and effective, achieving outcomes comparable to those for nonhilar lesions. This work, cited over 155 times, provided crucial evidence that robotic surgery can be successfully applied to the most anatomically demanding renal tumors, expanding treatment options for patients who might otherwise require radical nephrectomy. Berkman’s contributions have helped establish robotic partial nephrectomy as a standard approach for complex kidney cancers, reducing patient morbidity while preserving renal function. His research continues to influence surgical practice and training, with his studies frequently referenced in guidelines and surgical curricula.

Research Focus

Key Achievements

1
H-Index
1
Papers
155
Total Citations
155
Avg Citations/Paper
🏆 Most Cited Paper
Multi-Institutional Analysis of Robotic Partial Nephrectomy for Hilar Versus Nonhilar Lesions in 446 Consecutive Cases
155 citations · 2010
📈 Most Prolific Year: 2010 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: NYU Langone Health

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago